Periurethral implants in stress incontinence (injectables)
Authors:
V. Vik; R. Zachoval; M. Záleský; M. Galas
Published in:
Urol List 2008; 6(1): 48-54
Overview
Urinary incontinence has a major impact on the quality of life and has a great influence on physical, psychological and social welfare of patients. Decreased incidence of urinary incontinence, which is observed in male and female patients treated with injectables, improves dramatically their quality of life. All patients can resume their regular activities relatively soon after the surgery; the side effects are considerably milder in comparison with other surgical methods. Female patients with sfincteric insufficiency and/or urethral hypermobility or elderly patients with poor overall health are ideal candidates for this kind of therapy. In view of low morbidity, patients can undergo the procedure repeatedly or can have another type of surgery in case of failure. The differences between the materials used today are small and the choice of a specific injectable depends on the surgeon's preference and on the availability and price of the injectable.
Key words:
urinary incontinence, bulking agents, injectables
Sources
1. Urinary incontinence-ACOG Technical Bulletin, No. 213, October 1995. Int J Gynecol Obstet 1996; 52: 75-86.
2. Resnik N, Subbaro Y, Laurino E. Pathophysiology in urinary incontinence amongst institutionalised elderly persons. N Engl J Med 1989; 320: 1-7.
3. Ouslander J, Staskin D, Raz S et al. Clinical versus urodynamic diagnosis in an incontinent geriatric female population. J Urol 1987; 137: 68-71.
4. Nygaard IE, Lemke JH. Urinary Incontinence in Rural Older Women: prevalence, incidence and remission. J Am Geriatr Soc 1996; 44: 1049.
5. Goldstein M, Hawthorne ME, Engeberg S et al. Urinary incontinence. Why people do not seek help. J Gerontol Nurs 1992; 18: 15.
6. Holst K, Wilson PD. The prevalence of female urinary incontinence and reasons form not seeking treatment. NZ Med J 1988; 101: 756-758.
7. Beisland HO, Fossberg E, Noer A, Sander S. Urethral sphincter insufficiency in postmenopausal females: Treatment with phenylpropanolamin and estriol separately and in combination. Urol Int 1984; 39: 211-216.
8. Winters JC, Appell R. Periurethral injection of collagen in the treatment of intrinsic sphincter deficiency in the female patient. Urol Clin North Am 1995; 22: 673-678.
9. Monga AK, Stanton SL. Urodynamics: prediction, outcome and analysis of mechanism of cure of stress incontinence by periurethral collagen. Br J Obstet Gyneacol 1997; 104: 158-162.
10. Eckford SD, Abrams P. Para-urethral collagen implantation for female stress incontinence. Br J Urol 1991; 68: 586-589.
11. O'Connell HE, McGuire EJ, Aboseif S et al. Transurethral collagen therapy in women. J Urol 1995; 154: 1463-1465.
12. Kieswetter H, Fisher M, Wober L et al. Endoscopic implantation of collagen (GAX) for the treatment of urinary incontinence. Br J Urol 1992; 69: 22-25.
13. Monga AK, Robinson D, Stanton SL. Periurethral collagen injection for genuine stress incontinence: 2-year follow-up. Br J Urol 1995; 76: 156-160.
14. Corcos J, Fournier C. Periurethral collagen injection for the treatment of female stress urinary incontinence: 4-year follow-up results. Urology 1999; 54: 815-818.
15. Elsergany R, Ghoniem GM. Collagen injection for intrinsic sphincter deficiency in men: a reasonable option in selected patients. J Urol 1998; 159: 1504- 1506.
16. Faerber G. Endoscopic collagen injection therapy in elderly women with type I stress urinary incontinence. J Urol 1996; 155: 512-514.
17. Politano VA, Small MP, Harper JM, Lynne CM. Periurethral Teflon injection for urinary incontinence. J Urol 1974; 111: 180-183.
18. Quackles R. Deux incontinences apres adenomectmie gueries par injection de parrafine dans le perinee. Acta Urol Belg 1955; 107: 379-381.
19. Sachse S. Treatment of urinary incontinence with sclerosing agent solutions: Indication, results, complications. Urol Int 1963; 15: 225-244.
20. Politano AV. Periurethral polytetrafluoroethylene injection for urinary incontinence. J Urol 1982; 127: 439-442.
21. Berg S. Polytef augmentation urethroplasty correction of surgically incurable incontinence by injection technique. Arch Surg 1973; 107: 379-381.
22. Kershen RT, Atala A. New advances in injectables therapies for the treatment of incontinence and vesicourethral reflux. Urol Clin North Am 1999; 26: 81-94.
23. Dmochowski RR, Appell RA. Injectable agents in the treatment of stress urinary incontinence in women: where are we now? Urology 2000; 56: 32-40.
24. Frey P, Lutz N, Berger D et al. Histological behaviour of glutaraldehyde cross-linked bovine collagen injected into human bladder for the treatment of vesicoureteral reflux. J Urol 1994; 152: 632-635.
25. Remacle M, Marbaix E. Collagen implants in the human larynx. Pathological examinations of two cases. Arch Otorhinolaryngol 1988; 245: 203-209.
26. Bent AE, Foote J, Siegel S et al. Collagen implant for treating stress urinary incontinence in women with urethral hypermobility. J Urol 2001; 166: 1354-1357.
27. Swami S, Batista JE, Abrams P. Collagen for female genuine stress incontinence after a minimum 2-year follow-up. Br J Urol 1997; 80: 757-761.
28. Ang LP, Tay KP, Lim PH et al. Endoscopic injection of collagen for the treatment of female urinary stress incontinence. Int J Urol 1997; 4: 254-258.
29. Cross CA, English SF, Cespedes RD et al. A followup of transurethral collagen injection therapy for urinary incontinence. J Urol 1998; 159: 106-108.
30. Winters JC, Chiverton A, Scarpero HM et al. Collagen injection therapy in elderly women: long-term results and patients satisfaction. Urology 2000; 55: 856-861.
31. Stothers L, Goldenberg SL, Leone EF. Complications of periurethral collagen injection for stress urinary incontinence. J Urol 1998; 159: 806-807.
32. Buckley J, Scott R, Aitchison M at al. Periurethral Microplastique silicone injection for stress incontinence and vesicoureteric reflux. Minim Invasive Ther 1991; 1: 72.
33. Meschia M, Pifarotti P, Gattei U, Crosignani PG. Injection therapy for the treatment of stress urinary incontinence in women. Gynecol Obstet Invest 2002; 54: 67-72.
34. Lightner DJ, Calvosa C, Andersen R et al. A new injectable bulking agent for treatment of stress urinary incontinence: Results of a multicenter, randomised, controlled, double blind study of Durasphere. Urology 2001; 58: 12-15.
35. Chrouser KL, Fick F, Goel A et al. Carbon coated zirconium beads in beta-glucan gel and bovine glutaraldehyde cross-linked collagen injections for intrinsic sphincter deficiency: continence and satisfaction after extended follow-up. J Urol 2004; 171(3): 1152- 1155.
36. Madjar S, Sharma AK, Waltzer WC et al. Periurethral mass formations following bulking agent injection for the treatment of urinary incontinence. J Urol 2006; 175(4): 1408-1410.
37. Aaronson IA, Rames RA, Greene WB et al. Endoscopic treatment of reflux: Migration of Teflon to the lungs and brain. Eur Urol 1993; 23: 394-399.
38. Richard T, Kershen MD, Roger R et al. Beyond collagen: injectable therapies for the treatment of female stress urinary incontinence in the new millennium. Urol Clin N Am 2002; 29: 559-574.
39. Kerrebroeck P, Meulen F, Farrelly E et al. Treatment of urinary incontinence: recent developments in the role of urethral injection. Urol Res 2003; 30: 356- 362.
40. Lopez AE, Padron OF, Patsias G et al. Transurethral polytetrafuorethylene injection in female patients with urinary incontinence. J Urol 1993; 150: 856-858.
41. Stenberg A, Lackgren G. A new bioimplant for the endoscopic treatment of vesicoureteral reflux: experimental and short term clinical results. J Urol 1995; 154: 800-803.
42. Stenberg A, Larsson G, Johnson P et al. DiHA Dextran Copolymer, a new biocompatible material for endoscopic treatment of stress incontinent women. Short term results. Acta Obstet Gynecol Scand 1999; 78: 436-442.
43. Lavelle MT, Conlin MJ, Skoog SJ.: Subureteral injection of Deflux for correction of reflux: analysis of factors predicting success. Urology 2005; 65(3): 564-7.
44. Merrot T, Ouedraogo I, Hery G, Alessandrini P. Preliminary results of endoscopic treatment of vesicoureteric reflux in children. Prospective comparative study of Deflux vs. Coaptite. Prog Urol 2005; 15(6): 1114-1119.
45. Report From the 24th Annual Scientific Meeting of the American Urogynecology Society, September 11.-13. 2003, Hollywood, Florida.
46. Currie I, Drutz HP, Deck J et al. Adipose tissue and lipid droplet embolism following periurethral injection of autologous fat: case report and review of the literature. Int Urogynecol J Pelvic Floor Dysfunct 1997; 8: 377-380.
47. Bent AE, Tutrone RT, McLennan MT et al. Treatment of intrinsic sphincter deficiency using autologus ear chondrocytes as a bulking agent. Neurourol Urodyn 2001; 20: 157-165.
48. McGuire EJ, Fitzpatric CC, Wan J. Clinical assessment of urethral sphincter function. J Urol 1993; 150: 1452-1454.
49. terMeulen PH, Berghmans LCM, vanKerrebroeck EVA. Systematic Review: efficacy of silicone microimplants (Macroplastique) therapy for stress urinary incontinence in adult women. Eur Urol 2003; 44: 573- 582.
50. Haab F. Les injections peri-uretrales pour traitment de l´incontinence urinaire d´effort. Progres en Urologie 1997; 7: 293-296.
51. Šimon V, Halaška M, Otčenášek M et al. Použití hydrogelových bobtnavých implantátů v léčbě stresové incontinence moči u žen - pilotní studie. Čes Gynek 2002; 67: 148-151.
52. Appel AR, Dmochowski RR, Herschorn S. Urethra injections for female stress incontinence. BJU Int 2006; 98(supp1): 27-30.
Labels
Paediatric urologist UrologyArticle was published in
Urological Journal
2008 Issue 1
Most read in this issue
- Pelvic organ prolapse in women from the viewpoint of a urologist
-
Kolposuspenze dle Burche – zlatý standard v operacích ženské močové inkontinence
Současná urogynekologická operativa I - The Pathophysiology of Large Capacity Bladder
- Urological consequences of gynaecological surgeries